ArticleThe Journal of infectious diseases2021

Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.

Elizabeth J McFarland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.